Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6438983rdf:typepubmed:Citationlld:pubmed
pubmed-article:6438983lifeskim:mentionsumls-concept:C0005821lld:lifeskim
pubmed-article:6438983lifeskim:mentionsumls-concept:C0027022lld:lifeskim
pubmed-article:6438983lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:6438983lifeskim:mentionsumls-concept:C0391845lld:lifeskim
pubmed-article:6438983pubmed:issue3lld:pubmed
pubmed-article:6438983pubmed:dateCreated1985-1-9lld:pubmed
pubmed-article:6438983pubmed:abstractTextIn platelets of subjects affected with myeloproliferative disorders the following lysosomal enzymes were studied: alpha-mannosidase, alpha-fucosidase, beta-galactosidase, beta-glucosidase, beta-glucuronidase, beta-N-acetylglucosaminidase and acid phosphatase. For each enzyme the specific activity, the optimum of pH and buffer, Km and saturating substrate concentrations, as well as thermostability were determined. Control and patient enzymes showed no difference.lld:pubmed
pubmed-article:6438983pubmed:languageenglld:pubmed
pubmed-article:6438983pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6438983pubmed:citationSubsetIMlld:pubmed
pubmed-article:6438983pubmed:statusMEDLINElld:pubmed
pubmed-article:6438983pubmed:issn0001-5792lld:pubmed
pubmed-article:6438983pubmed:authorpubmed-author:MarescaMMlld:pubmed
pubmed-article:6438983pubmed:authorpubmed-author:LeonciniGGlld:pubmed
pubmed-article:6438983pubmed:authorpubmed-author:BalestreroFFlld:pubmed
pubmed-article:6438983pubmed:authorpubmed-author:ArmaniUUlld:pubmed
pubmed-article:6438983pubmed:authorpubmed-author:PianaAAlld:pubmed
pubmed-article:6438983pubmed:issnTypePrintlld:pubmed
pubmed-article:6438983pubmed:volume72lld:pubmed
pubmed-article:6438983pubmed:ownerNLMlld:pubmed
pubmed-article:6438983pubmed:authorsCompleteYlld:pubmed
pubmed-article:6438983pubmed:pagination190-4lld:pubmed
pubmed-article:6438983pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6438983pubmed:meshHeadingpubmed-meshheading:6438983-...lld:pubmed
pubmed-article:6438983pubmed:meshHeadingpubmed-meshheading:6438983-...lld:pubmed
pubmed-article:6438983pubmed:meshHeadingpubmed-meshheading:6438983-...lld:pubmed
pubmed-article:6438983pubmed:meshHeadingpubmed-meshheading:6438983-...lld:pubmed
pubmed-article:6438983pubmed:meshHeadingpubmed-meshheading:6438983-...lld:pubmed
pubmed-article:6438983pubmed:meshHeadingpubmed-meshheading:6438983-...lld:pubmed
pubmed-article:6438983pubmed:meshHeadingpubmed-meshheading:6438983-...lld:pubmed
pubmed-article:6438983pubmed:meshHeadingpubmed-meshheading:6438983-...lld:pubmed
pubmed-article:6438983pubmed:meshHeadingpubmed-meshheading:6438983-...lld:pubmed
pubmed-article:6438983pubmed:year1984lld:pubmed
pubmed-article:6438983pubmed:articleTitlePlatelet lysosomal enzymes are normal in myeloproliferative disorders.lld:pubmed
pubmed-article:6438983pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6438983pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed